{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:35:09Z","timestamp":1792506909054,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,6]],"date-time":"2023-08-06T00:00:00Z","timestamp":1691280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["1381035-F"],"award-info":[{"award-number":["1381035-F"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["FPU20\/06329"],"award-info":[{"award-number":["FPU20\/06329"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["RyC- 2017\\u201323437"],"award-info":[{"award-number":["RyC- 2017\\u201323437"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["FI21\/00039"],"award-info":[{"award-number":["FI21\/00039"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["1381035-F"],"award-info":[{"award-number":["1381035-F"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["P20_01367"],"award-info":[{"award-number":["P20_01367"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI20\/00079"],"award-info":[{"award-number":["PI20\/00079"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RICOR-RD21\/0002\/0033"],"award-info":[{"award-number":["RICOR-RD21\/0002\/0033"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/00591"],"award-info":[{"award-number":["PI21\/00591"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018943","name":"Consejer\u00eda de Conocimiento, Investigaci\u00f3n y Universidad, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018943","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ejim.2023.08.002","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T16:15:38Z","timestamp":1691165738000},"page":"49-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Clinical features and immune mechanisms directly linked to the altered liver function in patients with rheumatoid arthritis"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1145-4935","authenticated-orcid":false,"given":"I","family":"Arias-de la Rosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ruiz-Ponce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1450-8131","authenticated-orcid":false,"given":"L","family":"Cuesta-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"P\u00e9rez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0014-3816","authenticated-orcid":false,"given":"F","family":"Leiva-Cepas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4578-2179","authenticated-orcid":false,"given":"MD","family":"Gahete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6293-2570","authenticated-orcid":false,"given":"P","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7552-3469","authenticated-orcid":false,"given":"R","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8787-2706","authenticated-orcid":false,"given":"J","family":"Cordoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0319-4456","authenticated-orcid":false,"given":"E","family":"P\u00e9rez-Pampin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1183-1072","authenticated-orcid":false,"given":"AJ","family":"Lucendo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7647-6289","authenticated-orcid":false,"given":"E","family":"Collantes-Est\u00e9vez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ch","family":"L\u00f3pez-Pedrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Escudero-Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Barbarroja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2023.08.002_bib0001","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1586\/17474124.2016.1095088","article-title":"The management of autoimmunity in patients with cholestatic liver diseases","volume":"10","author":"Ali","year":"2016","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2023.08.002_bib0002","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/art.24390","article-title":"Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis","volume":"61","author":"L\u00f3pez-Longo","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2023.08.002_bib0003","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1161\/ATVBAHA.114.304475","article-title":"Anticyclic citrullinated protein antibodies are implicated in the development of cardiovascular disease in rheumatoid arthritis","volume":"34","author":"Barbarroja","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejim.2023.08.002_bib0004","doi-asserted-by":"crossref","first-page":"g4596","DOI":"10.1136\/bmj.g4596","article-title":"Non-alcoholic fatty liver disease","volume":"349","author":"Sattar","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2023.08.002_bib0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cld.2010.09.006","article-title":"Rheumatologic disease and the liver","volume":"15","author":"Schlenker","year":"2011","journal-title":"Clin in Liver Dis"},{"key":"10.1016\/j.ejim.2023.08.002_bib0006","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/ar3319","article-title":"Liver involvement in subjects with rheumatic disease","volume":"13","author":"Selmi","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ejim.2023.08.002_bib0007","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00296-018-4021-5","article-title":"Clinical connection between rheumatoid arthritis and liver damage","volume":"38","author":"Radovanovi\u0107-Dini\u0107","year":"2018","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.ejim.2023.08.002_bib0008","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s11926-012-0300-4","article-title":"Effect and treatment of chronic pain in inflammatory arthritis","volume":"15","author":"Lee","year":"2013","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.ejim.2023.08.002_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203084","article-title":"Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment","volume":"13","author":"Mori","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ejim.2023.08.002_bib0010","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/1573397116666200319155247","article-title":"Liver fibrosis in rheumatoid arthritis patients treated with methotrexate","volume":"16","author":"Hilal","year":"2020","journal-title":"Curr Rheumatol Rev"},{"key":"10.1016\/j.ejim.2023.08.002_bib0011","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2023.08.002_bib0012","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/gast.2002.35354","article-title":"The utility of radiological imaging in nonalcoholic fatty liver disease","volume":"123","author":"Saadeh","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2023.08.002_bib0013","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2023.08.002_bib0014","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis","volume":"53","author":"Lin","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2023.08.002_bib0015","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.12688\/f1000research.12170.1","article-title":"Optimal cutoff for the evaluation of insulin resistance through triglyceride-glucose index: a cross-sectional study in a Venezuelan population","volume":"6","author":"Salazar","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.ejim.2023.08.002_bib0016","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12944-017-0409-6","article-title":"The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease","volume":"16","author":"Zhang","year":"2017","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.ejim.2023.08.002_bib0017","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"42","author":"Lee","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ejim.2023.08.002_bib0018","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/jgh.13814","article-title":"Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes","volume":"33","author":"Svikl\u0101ne","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2023.08.002_bib0019","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1023\/B:BILE.0000019559.84305.47","article-title":"Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: bestKeeper\u2013Excel-based tool using pair-wise correlations","volume":"26","author":"Pfaffl","year":"2004","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.ejim.2023.08.002_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.692242","article-title":"Pathogenic role of circulating citrullinated antigens and anti-cyclic monoclonal citrullinated peptide antibodies in rheumatoid arthritis","volume":"12","author":"Won","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejim.2023.08.002_bib0021","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/joim.12743","article-title":"Defective glucose and lipid metabolism in rheumatoid arthritis is determined by chronic inflammation in metabolic tissues","volume":"284","author":"Arias de la Rosa","year":"2018","journal-title":"J Intern Med"},{"key":"10.1016\/j.ejim.2023.08.002_bib0022","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.ejim.2023.08.002_bib0023","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3920196","article-title":"The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD)","volume":"2020","author":"Tanase","year":"2020","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.ejim.2023.08.002_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.997270","article-title":"Nonalcoholic fatty liver disease in inflammatory arthritis: relationship with cardiovascular risk","volume":"13","author":"Barbarroja","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejim.2023.08.002_bib0025","first-page":"5","article-title":"The roles of anti-citrullinated protein antibodies in the immunopathogenesis of rheumatoid arthritis","volume":"31","author":"Yu","year":"2019","journal-title":"Ci Ji Yi Xue Za Zhi"},{"key":"10.1016\/j.ejim.2023.08.002_bib0026","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/14728222.2017.1294160","article-title":"PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritis","volume":"21","author":"Koushik","year":"2017","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.ejim.2023.08.002_bib0027","first-page":"403","article-title":"Circulating levels of citrullinated and MMP-degraded vimentin (VICM) in liver fibrosis related pathology","volume":"4","author":"Vassiliadis","year":"2012","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.ejim.2023.08.002_bib0028","first-page":"165","article-title":"[Screening of citrullinated proteins in ten tumor cell lines]","volume":"37","author":"Zhang","year":"2015","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"10.1016\/j.ejim.2023.08.002_bib0029","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/jat.1228","article-title":"Oxidative status of DBA\/1J mice with type II collagen-induced arthritis","volume":"27","author":"Choi","year":"2007","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.ejim.2023.08.002_bib0030","first-page":"222","article-title":"Anti-TNF-alpha therapy does not modulate leptin in patients with severe rheumatoid arthritis","volume":"27","author":"Gonz\u00e1lez-Gay","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ejim.2023.08.002_bib0031","first-page":"596","article-title":"High-grade inflammation, circulating adiponectin concentrations and cardiovascular risk factors in severe rheumatoid arthritis","volume":"26","author":"Gonz\u00e1lez-Gay","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ejim.2023.08.002_bib0032","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/949157","article-title":"Innate immune cells in liver inflammation","volume":"2012","author":"Liaskou","year":"2012","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.ejim.2023.08.002_bib0033","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1007\/s10067-021-05678-8","article-title":"Prevalence of liver fibrosis by Fibroscan in patients on long-term methotrexate therapy for rheumatoid arthritis","volume":"40","author":"Bafna","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ejim.2023.08.002_bib0034","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/1756-185X.13576","article-title":"Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: a long-term follow-up of predictors, surveillance, and outcome in clinical practice","volume":"22","author":"Karlsson Sundbaum","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.ejim.2023.08.002_bib0035","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3899\/jrheum.211281","article-title":"Using FibroScan to assess for the development of liver fibrosis in patients with arthritis on methotrexate: a single-center experience","volume":"49","author":"Darabian","year":"2022","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2023.08.002_bib0036","doi-asserted-by":"crossref","first-page":"3541","DOI":"10.2337\/diabetes.54.12.3541","article-title":"Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients","volume":"54","author":"Targher","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.ejim.2023.08.002_bib0037","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2017-000458","article-title":"Obesity is a strong predictor of worse clinical outcomes and treatment responses in early rheumatoid arthritis: results from the SWEFOT trial","volume":"3","author":"Levitsky","year":"2017","journal-title":"RMD Open"},{"key":"10.1016\/j.ejim.2023.08.002_bib0038","doi-asserted-by":"crossref","first-page":"18634","DOI":"10.1038\/s41598-020-75673-7","article-title":"Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs","volume":"10","author":"Abuhelwa","year":"2020","journal-title":"Sci Rep"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523002856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523002856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:26:53Z","timestamp":1777595213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620523002856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":38,"alternative-id":["S0953620523002856"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2023.08.002","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical features and immune mechanisms directly linked to the altered liver function in patients with rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2023.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}]}}